For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Quick Links
Nicotine, alcohol and other drug dependencies drugsNicotine, alcohol and other drug dependencies drugs
Browse our health professional information, resources and educational activities on nicotine, alcohol and other drug dependencies drugs.
| Title | Description | Content type | Date* |
|---|---|---|---|
| Varenicline (Champix) for smoking cessation | Review of varenicline (Champix) for smoking cessation, including adverse effects, treatment efficacy, and drug interactions. | Professional publication - NPS RADAR - Review | 2011-08-01 00:00:00 |
| Cardiovascular risk calculators | Tools to help health professionals assess a patient’s cardiovascular risk and treatment benefit. | Tool - Health Professional | 2009-03-12 00:00:00 |
| Varenicline (Champix) safety update: serious neuropsychiatric and dermatological adverse events | Safety update regarding serious neuropsychiatric and dermatological adverse events associated with varenicline (Champix) | Professional publication - NPS RADAR - Brief item | 2009-12-01 00:00:00 |
| Assessing nicotine dependence | Questions to ask to make a rapid assessment of nicotine dependence. | Professional publication - NPS RADAR - Web only item | 2011-02-01 00:00:00 |
| Varenicline (Champix) — new PBS listing for extra 12 weeks of therapy | Authority PBS listing for a further 12 weeks of varenicline (Champix) for smoking cessation from 1 February 2011. | Professional publication - NPS RADAR - Brief item | 2011-02-01 00:00:00 |
| Nicotine patches for Aboriginal and Torres Strait Islander people | Information about PBS subsidising of Nicotine patches for Aboriginal and Torres Strait Islander people | Professional publication - NPS RADAR - Brief item | 2008-12-01 00:00:00 |
| NPS News 4: Managing withdrawal from benzodiazepines and alternatives for night-time sedation | Guidelines for withdrawing patients from benzodiazepines, including prescribing pointers, complementary therapies, and benzodiazepine dose equivalents. | Professional publication - NPS News | 1999-06-01 00:00:00 |
| Evaluation of prescription drugs in Australia | A synopsis of the evaluation, dosage management and regulation of drugs in Australia, along with issues surrounding approaches to new drugs | Professional publication - NPS News | 2001-12-01 00:00:00 |
| NPS Prescribing Practice Review 20: Smoking cessation | Information on the stages of change in smoking cessation, non-drug therapy in those ready to quit, and the use of nicotine replacement therapy and bupropion. | Professional publication - Prescribing Practice Review | 2002-10-30 00:00:00 |
| Clinical audit: Management of stable COPD and smoking cessation | How are you managing your patients with stable chronic obstructive pulmonary disease who are current smokers? Review 10 patients | Professional activity - Clinical audit | 2010-05-01 00:00:00 |
| Quit smoking | Outlines quit smoking strategies and role of nicotine replacement and Champix. Discusses COPD (chronic obstructive pulmonary disease) and its diagnosis. | Professional publication - NPS News | 2010-04-01 00:00:00 |
| Drug and alcohol management | Reviews drug and non-drug interventions for alcohol problems and smoking cessation. Case study on problem drinking | Professional publication - NPS News | 2002-06-01 00:00:00 |
| Case study 63: Managing chronic obstructive pulmonary disease | Damien, a 58-year-old brick layer comes for a review of the management of his chronic obstructive pulmonary disease (COPD) as his symptoms have become more troublesome over the past month. | Professional activity - Case study | 2010-04-01 00:00:00 |
| NPS News 5: Bronchodilator therapy and corticosteroids for chronic obstructive pulmonary disease | Diagnosing COPD; bronchodilators and corticosteroids in treatment; nicotine replacement therapy for smoking cessation, and a report on case study 2 (otitis media). Otitis media case study | Professional publication - NPS News | 1999-08-01 00:00:00 |
| NSAIDs: minimising the risk (pharmacy letter) | Pharmacy letter insert with advice on appropriate use of NSAIDs to minimise risk to patients from their use. | Professional publication - Pharmacy Letter | 1999-11-28 00:00:00 |
Useful information from Australian Prescriber
| Content type | Date | Title |
|---|---|---|
| Australian Prescriber - Article | 2006-08-01 00:00:00 | Psychostimulant poisoning |
| Australian Prescriber - Article | 2006-04-01 00:00:00 | Managing hepatitis C in the community |
| Australian Prescriber - Article | 2005-06-01 00:00:00 | What's new in smoking cessation? |
| Australian Prescriber - Article | 2005-02-01 00:00:00 | Should consumers be warned about aspirin, alcohol and gastric bleeding? |
| Australian Prescriber - Article | 2004-06-01 00:00:00 | Temazepam capsules: what was the problem? |
| Australian Prescriber - Article | 2004-02-01 00:00:00 | Alcohol and paracetamol |
| Australian Prescriber - Article | 2002-06-01 00:00:00 | Management of the heavy drinker in primary care |
| Australian Prescriber - Article | 2001-04-01 00:00:00 | Bupropion |
| Australian Prescriber - Article | 2001-02-01 00:00:00 | Drug treatment for opioid dependence |
| Australian Prescriber - Article | 1997-08-01 00:00:00 | Drug-seeking behaviour |
Date published: 2009-09-20 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
